MSD’s 125 years of global operations has been pushing the boundaries of science around the world with the intention that its prescription products will accelerate healthcare innovation for all. As a policy, the company supports ongoing assessments to understand infectious disease trends and their threat to public health. It also invests in improving the flow of pharmaceuticals from production to patient in order to ensure reliable product supply and affordability. “One of the most crucial challenges in healthcare is access to medicines and vaccination services. MSD continues to conduct and support programs that help identify new approaches to increase awareness and immunization coverage rates.

Source: Manila Times August 23, 2020 17:03 UTC